[Comparative trial between two drugs in the treatment of vomiting induced by anti-cancer chemotherapy (author's transl)].
In order to prevent vomiting induced by anti-cancer chemotherapy, the efficiency of domperidone has been compared to metoclopramide in a randomised trial. No difference has been observed between both emetic treatments.
D000932:Antiemetics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects; D001562:Benzimidazoles / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004294:Domperidone; D005260:Female; D006801:Humans; D008297:Male; D008787:Metoclopramide / Q000627:therapeutic use*; D010880:Piperidines / Q000627:therapeutic use*; D011897:Random Allocation; D014839:Vomiting / Q000139:chemically induced / Q000517:prevention & control*
D000932:Antiemetics; D000970:Antineoplastic Agents; D001562:Benzimidazoles; D010880:Piperidines; D004294:Domperidone; D008787:Metoclopramide
Essai comparatif de deux médicaments dans le traitement des vomissements induits par la chimiothérapie anti-cancéreuse.